INTERCEPT PHARMACEUTICALS INC 4
4 · INTERCEPT PHARMACEUTICALS INC · Filed Jul 8, 2015
Insider Transaction Report
Form 4
Adorini Luciano
Chief Scientific Officer
Transactions
- Sale
Common Stock
2015-07-06$238.64/sh−367$87,580→ 13,809 total - Sale
Common Stock
2015-07-06$241.57/sh−1,000$241,571→ 11,609 total - Exercise/Conversion
Common Stock
2015-07-06$21.50/sh+4,000$86,000→ 14,776 total - Exercise/Conversion
Option to Purchase Common Stock
2015-07-06−67→ 0 totalExercise: $8.67Exp: 2021-10-13→ Common Stock (67 underlying) - Sale
Common Stock
2015-07-06$2538.02/sh−600$1,522,815→ 14,176 total - Sale
Common Stock
2015-07-06$241.81/sh−770$186,194→ 10,839 total - Sale
Common Stock
2015-07-06$240.63/sh−1,200$288,752→ 12,609 total - Exercise/Conversion
Option to Purchase Common Stock
2015-07-06−4,000→ 2,923 totalExercise: $21.50Exp: 2022-11-16→ Common Stock (4,000 underlying) - Exercise/Conversion
Common Stock
2015-07-06$8.67/sh+67$581→ 10,776 total - Sale
Common Stock
2015-07-06$243.69/sh−130$31,680→ 10,709 total
Footnotes (8)
- [F1]The reported transaction was made pursuant to a 10(b)5-1 plan adopted by the reporting person on March 9, 2015.
- [F2]All the shares underlying this option have fully vested.
- [F3]The remaining shares underlying this option vest on a pro rata monthly basis through January 1, 2016, subject to the terms and conditions of the award and the Intercept Pharmaceuticals, Inc. 2012 Equity Incentive Plan.
- [F4]This transaction was executed in multiple trades at prices ranging from $237.52 to $238.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]This transaction was executed in multiple trades at prices ranging from $238.55 to $238.87. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F6]This transaction was executed in multiple trades at prices ranging from $240.00 to $240.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F7]This transaction was executed in multiple trades at prices ranging from $241.0150 to $242.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F8]This transaction was executed in multiple trades at prices ranging from $242.3200 to $242.9600. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.